More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Shelled Eggs
Antitrust, Commodities
On June 8, Lowey Dannenberg Chairman Vincent Briganti was appointed as Co-Lead Counsel for the Direct Purchaser Plaintiffs in In Re: Shell Eggs Antitrust Litigation, No. 3:26-md-03175-JDP (W.D. Wisc.) Plaintiffs […]
Amitza
Healthcare
Lowey Dannenberg, on behalf of named plaintiff Premera Blue Cross, is leading a class on behalf of Third-Party Payers of Amitiza (Lubiprostone) against Takeda Pharmaceutical Company Ltd. and related entities. […]
Amgen
Health Care, Healthcare
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]
News
Former Assistant Attorney General Joseph Nielsen Joins Lowey Dannenberg as Partner
Lowey Dannenberg, P.C. is pleased to welcome its newest partner, Joseph Nielsen, to the firm. Joe built a storied career in private and public roles representing victims of antitrust conspiracies in the technology and pharmaceutical industries. During his 19 years at...
Blog
How Do SPACs Differ From Traditional Companies?
SPAC stands for “special purpose acquisition company,” which is also known as “blank check company.” It typically refers to a shell company listed on a stock exchange with the purpose of acquiring a private company, thus making it public without going through the expensive initial public offering...